Drug giant rolls out Siebel to provide global trial view

Share this content

Drug development giant Inveresk Research is rolling out Siebel Clinical to optimise its clients' drug development process and replace Inveresk's clinical trial management systems with a coordinated, global view of every trial.

Siebel Pharma's Web-based clinical trial management solution will be used to streamline clients' product development process by creating a shared, real-time view of investigator relationships, clinical research associate activities, and clinical trial status. Inveresk expects to increase the efficiency and effectiveness of its clinical trials and in the process enhance its relationships with pharmaceutical and biotechnology customers worldwide.

More than 1,000 Inveresk clinical employees in 20 countries will have access to a single repository of investigator, site coordinator, and patient information. Inveresk will use Siebel Clinical to track study site trip reports; clinical trial status, activity, and calendar management; management reports; and regulatory information. By automating several clinical trial processes and compressing clinical trial timelines, Siebel Clinical is expected to simplify patient recruitment.

"The functionality of Siebel Clinical will allow Inveresk to share clinical trial information across teams and deliver superior services and support to our clients," said Alastair McEwan, President, Global Clinical, Inveresk Research Group, Inc. "By streamlining trial planning and the coordination of activities, Inveresk will optimise resource allocation, increase efficiency, and reduce development costs for our clients."


Please login or register to join the discussion.

There are currently no replies, be the first to post a reply.